Poiesis Medical Coo Frank D'ambra at The In3 360 Medical Device Investory Conference

I'm Frank D' Ambra the Chief Operating Officer of Poiesis MEDICAL located across the Florida Poeisis has developed the next generation of indwelling urinary catheters called the Duette™ which will be we believe a replacement for the standard Foley catheters that are in the market today. What's unique about the Duette™ is that it adds a second balloon onto the Foley catheter where the tip is located so that when that balloon is inflated the tip is completely subsumed within the balloon and that's important for a couple of reasons. First is that all Foley catheters once they are inserted the bladder begin to drain, the bladder literally collapses on to the Foley itself, so that tip basically erodes into the mucosal lining of the bladder, and the mucosal lining is your body's natural defense against infection. Second thing that happen is that as the bladder collapses around like the catheter is that the bladder wall mucosal lining again is literary sucked into the drainage eyes of the Foley catheter, so that's the second source of damage so what the Duette™ does is by adding a second balloon, it prevents that damage from occurring, when the bladder collapses that energy is now disperse over the surface area of the balloon, so the balloon acts like a pillow and the balloons acts as a standoff to the bladder wall to prevent the wall from being sucked into the drainage eyes of the catheter. The Duette™ is designed to reduce trauma in the reason that is so critical its that trauma site becomes the primary point of bacterial attachment which leads to urinary tract infections ( UTI ) that is the most common hospital recorded infection today so the Duette™ is design in addition to providing better total care to the patient, it's also being design to bring down the rate CAUTI infection The market opportunity for the Duette™ is to replace the Foley catheters that are out there today in the US Foley catheter sales are in the neighborhood of 750Million Dollars, worldwide, there's another Billion and a half to Billion and three quarters of sales that are occurring and with the aging of the population worldwide it's expected that Foley catheters utilization will increase in the range of 8 to 10 percent a year for the sale of the foreseeable future, in the next 6 to 12 months we will fully commercialize the opportunity that is the Duette™. The opportunity to invest in Poiesis now is obviously an opportunity to get in at the ground floor of a product that we believe will be market disruptive and can clearly become a new standard of care in indwelling urinary catheters.